Glaucoma Building Blocks | ASCRS
An Educational Series For Comprehensive Glaucoma Management

Glaucoma Building Blocks

Program Overview

The Glaucoma Building Blocks CME program is a multi-part educational series targeted for the comprehensive ophthalmologist, covering what you need to know to diagnose, follow, and treat your patients. This series consists of four episodes, the first three of which launched virtually with the fourth offered in person at the 2021 ASCRS Annual Meeting. All episodes are available virtually on demand now! Register Now!

Glaucoma Building Blocks covers a range of topics including diagnosis and monitoring, initial therapy, pharmaceuticals and innovation in drug delivery, laser therapy, the surgical landscape, and MIGS. Each interrelated episode features leading experts sharing their personal experience and surgical pearls in glaucoma management and treatment.

Register Now
Session audience

All Episodes Available On Demand Now

Earn 4.0 AMA PRA Category 1 Credits™ by participating in all four episodes of Glaucoma Building Blocks:

  • Episode 1: Diagnosing, Monitoring, and Choosing Therapy Options for Your Glaucoma Patient
  • Episode 2: Laser and Drug Delivery for Compliance-Independent IOP Control
  • Episode 3: ABC's of Glaucoma Surgery
  • Episode 4: Special Consideration for MIGS

PLEASE NOTE: Registered users will have access to all 4 modules when logged in.

Learn More

Program Features

  • 4 AMA PRA Category 1 Credits TM
  • A faculty of over 15 leading surgeons
  • Curriculum tailored to anterior segment specialists and comprehensive ophthalmologists
  • Flexibility—learn at your own pace with all episodes recorded and available on demand now
  • Complimentary registration for U.S. and international residents and fellows
Doctor listening to virtual meeting

Program Planning Co-Chairs

Leon Herndon

Leon Herndon, MD


Douglas J. Rhee, MD

Douglas Rhee, MD


Manjool Shah, MD


Thomas W. Samuelson, MD

Thomas Samuelson, MD


We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.